Beste Reproduktionsmediziner - TOP-325 Ärzte

Professor Dr. Selman Lacin graduated from the Faculty of Gulhane Military Medical Academy In 1988 and was a resident in Obstetrics and Gynecology in Izmir Dokuz Eylul University in between 1991 and 1996.


Prof. Dr.Selman Laçin, began as an assistant professor at the University of Celal Bayar of Manisa, has taken the degree of Associate Professor in 2002. After 8 years in academic medicine, he moved to Istanbul. 

He worked for different periods in Swedish Karolinska Institute,Department of OB / GYN, Israel Tel-Aviv University, assisted reproduction and IVF Center and Gulhane Military Medical Academy of IVF Center .

There are over 80 articles published in scientific journals at home and abroad and scientific contribution to the writing of the many books.

Between 2004 - 2007, he worked at the Istanbul Memorial Hospital IVF Center.
He established and directed the Medical Park Hospital IVF Center during 2007 - 2008. He began working in Medicana Health Group in 2008.

Professor Laçin is the member of many professional and social organizations at home and abroad.His main areas of interest are Hormonal Disorders, Infertility, IVF and Gynecologic Endoscopic (laparoscopic and hysteroscopic) Surgery. 

Prof. Dr. Selman Laçin is now the director of the Medicana International Hospital IVF Center in Beylikduzu, İstanbul, Turkey

EXPERIENCE*

2019 - Present, Istanbul/Istanbul/Turkey

MEMORIAL ATAŞEHİR HOSPITAL

General Surgeon

2012 - 2019, Diyarbakır/Diyarbakır/Turkey

DİCLE UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2011 - 2012, Van/Van/Turkey

VAN REGIONAL TRAINING AND RESEARCH HOSPITAL

General Surgeon

2009 - 2011, Van/Van/Turkey

HAKKARİ STATE HOSPITAL

General Surgeon

2004 - 2009, Van/Van/Turkey

YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2002 - 2004, Van/Van/Turkey

HACIBEKİR HEALTH CENTER

General Practitioner

*EDUCATION*

2018 - 2019, Diyarbakır/Turkey

Associate Professor

2015, Ohio/USA

OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

Neck Dissection Training

2012 - 2018, Diyarbakır/Turkey

Assistant Professor

1996 - 2002, Adana/Turkey

ÇUKUROVA UNIVERSITY

FACULTY OF MEDICINE - Medical Doctor Education

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

• Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
• Breast cancer
• Solid tumor diagnosis
• Digestive cancer
• Gynecological cancer
• Lung cancer
• Genitourinary cancer
• Sarcoma

Awards & Achievements

• Award from Himaya Foundations and University of Sharjah

Research & Publications

• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
• The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
• Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
• First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21

• Bekannt für fortschrittliche Fruchtbarkeitsbehandlungen: IVF, ICSI.
• Ärztlicher Direktor einer renommierten Fruchtbarkeitsklinik.
• Private Gynäkologiepraxis seit 2015 mit Schwerpunkt auf reproduktiver Gesundheit.
• Erfolgreiches Fruchtbarkeitsprojekt im Jahr 2019 gestartet.
• Experte für die Behandlung von Unfruchtbarkeit, Endometriose, PCOS und männlicher Unfruchtbarkeit.
• Internationale Praxis in Reproduktionsmedizin und -technologien.
• Bietet Fernberatungen zu Fruchtbarkeitsproblemen und -behandlungen.